Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Post

Showing results (211-220 of 215) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 215 results.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Cancer Research|October 7, 2004
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisScott M Wilhelm, Christopher Carter, Liya Tang, et al.
Cell Reports|January 26, 2016
Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 InhibitorsMark R Woodford, Andrew W Truman, Diana M Dunn, et al.
JCI Insight|November 27, 2025
Diagnosis of head and neck cancer by AI-based tumor-educated platelet RNA profiling of liquid biopsiesN E Wondergem, J B Poell, S G J G In 't Veld, et al.
Nature Microbiology|August 22, 2025
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formationDiana M Battaglia, Claire E Post, Wenbo Yao, et al.
Pageof 22

Showing results (211-220 of 215) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 215 results.
Oncotarget|February 18, 2017
Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancerC Allison Stewart, Pan Tong, Robert J Cardnell, et al.
Cancer Research|October 7, 2004
BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesisScott M Wilhelm, Christopher Carter, Liya Tang, et al.
Cell Reports|January 26, 2016
Mps1 Mediated Phosphorylation of Hsp90 Confers Renal Cell Carcinoma Sensitivity and Selectivity to Hsp90 InhibitorsMark R Woodford, Andrew W Truman, Diana M Dunn, et al.
JCI Insight|November 27, 2025
Diagnosis of head and neck cancer by AI-based tumor-educated platelet RNA profiling of liquid biopsiesN E Wondergem, J B Poell, S G J G In 't Veld, et al.
Nature Microbiology|August 22, 2025
SARS-CoV-2 infection induces pro-fibrotic and pro-thrombotic foam cell formationDiana M Battaglia, Claire E Post, Wenbo Yao, et al.
Pageof 22